125 related articles for article (PubMed ID: 7816323)
21. Low doses of the glycine/NMDA receptor antagonist R-(+)-HA-966 but not D-cycloserine induce paroxysmal activity in limbic brain regions of kindled rats.
Wlaź P; Ebert U; Löscher W
Eur J Neurosci; 1994 Nov; 6(11):1710-9. PubMed ID: 7874310
[TBL] [Abstract][Full Text] [Related]
22. N-methyl-D-aspartate receptor-mediated changes in thermal nociception: allosteric modulation at glycine and polyamine recognition sites.
Kolhekar R; Meller ST; Gebhart GF
Neuroscience; 1994 Dec; 63(4):925-36. PubMed ID: 7535397
[TBL] [Abstract][Full Text] [Related]
23. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline.
Witkin JM; Steele TD; Sharpe LG
J Pharmacol Exp Ther; 1997 Jan; 280(1):46-52. PubMed ID: 8996180
[TBL] [Abstract][Full Text] [Related]
24. NMDA receptor antagonists, MK-801 and ACEA-1011, prevent the development of tonic pain following subcutaneous formalin.
Vaccarino AL; Marek P; Kest B; Weber E; Keana JF; Liebeskind JC
Brain Res; 1993 Jul; 615(2):331-4. PubMed ID: 8364741
[TBL] [Abstract][Full Text] [Related]
25. The contribution of the different binding sites of the N-methyl-D-aspartate (NMDA) receptor to the expression of behavior.
Kretschmer BD; Zadow B; Volz TL; Volz L; Schmidt WJ
J Neural Transm Gen Sect; 1992; 87(1):23-35. PubMed ID: 1346965
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist.
Baron BM; Harrison BL; Kehne JH; Schmidt CJ; van Giersbergen PL; White HS; Siegel BW; Senyah Y; McCloskey TC; Fadayel GM; Taylor VL; Murawsky MK; Nyce P; Salituro FG
Eur J Pharmacol; 1997 Apr; 323(2-3):181-92. PubMed ID: 9128837
[TBL] [Abstract][Full Text] [Related]
27. Antagonists at the NMDA recognition site and blockers of the associated ion channel induce spontaneous tail-flicks in the rat.
Millan MJ
Eur J Pharmacol; 1991 Oct; 203(2):315-8. PubMed ID: 1724759
[TBL] [Abstract][Full Text] [Related]
28. Differential effects of glycine on the anticonvulsant activity of D-cycloserine and L-701,324 in mice.
Wlaź P; Poleszak E
Pharmacol Rep; 2011; 63(5):1231-4. PubMed ID: 22180366
[TBL] [Abstract][Full Text] [Related]
29. Effects of N-methyl-D-aspartate agonists and antagonists in rats discriminating amphetamine.
Gaiardi M; Gubellini C; Dall'Olio R; Gandolfi O; Bartoletti M
Behav Pharmacol; 2001 Sep; 12(5):317-24. PubMed ID: 11710746
[TBL] [Abstract][Full Text] [Related]
30. Probing the modulation of acute ethanol intoxication by pharmacological manipulation of the NMDAR glycine co-agonist site.
Debrouse L; Hurd B; Kiselycznyk C; Plitt A; Todaro A; Mishina M; Grant SG; Camp M; Gunduz-Cinar O; Holmes A
Alcohol Clin Exp Res; 2013 Feb; 37(2):223-33. PubMed ID: 22934986
[TBL] [Abstract][Full Text] [Related]
31. Effects of (+)-HA-966, CGS-19755, phencyclidine, and dizocilpine on repeated acquisition of response chains in pigeons: systemic manipulation of central glycine sites.
Campbell CM; Butelman ER; Woods JH
J Pharmacol Exp Ther; 1999 Apr; 289(1):521-7. PubMed ID: 10087045
[TBL] [Abstract][Full Text] [Related]
32. The glycine/NMDA receptor antagonist HA-966 impairs visual recognition memory in rhesus monkeys.
Matsuoka N; Aigner TG
Brain Res; 1996 Aug; 731(1-2):72-8. PubMed ID: 8883856
[TBL] [Abstract][Full Text] [Related]
33. Effects of D-cycloserine and (+)-HA-966 on the locomotor stimulation induced by NMDA antagonists and clonidine in monoamine-depleted mice.
Carlsson ML; Engberg G; Carlsson A
J Neural Transm Gen Sect; 1994; 95(3):223-33. PubMed ID: 7865177
[TBL] [Abstract][Full Text] [Related]
34. Desensitization of the NMDA receptor complex by glycinergic ligands in cerebellar granule cell cultures.
Boje KM; Wong G; Skolnick P
Brain Res; 1993 Feb; 603(2):207-14. PubMed ID: 8096423
[TBL] [Abstract][Full Text] [Related]
35. Discriminative stimulus effects of R-(+)-3-amino-1-hydroxypyrrolid-2-one, [(+)-HA-966], a partial agonist of the strychnine-insensitive modulatory site of the N-methyl-D-aspartate receptor.
Witkin JM; Brave S; French D; Geter-Douglass B
J Pharmacol Exp Ther; 1995 Dec; 275(3):1267-73. PubMed ID: 8531091
[TBL] [Abstract][Full Text] [Related]
36. Modulation of [3H]MK-801 binding to NMDA receptors in vivo and in vitro.
Murray F; Kennedy J; Hutson PH; Elliot J; Huscroft I; Mohnen K; Russell MG; Grimwood S
Eur J Pharmacol; 2000 Jun; 397(2-3):263-70. PubMed ID: 10844123
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological characterization of glycine-activated currents in HEK 293 cells expressing N-methyl-D-aspartate NR1 and NR3 subunits.
Smothers CT; Woodward JJ
J Pharmacol Exp Ther; 2007 Aug; 322(2):739-48. PubMed ID: 17502428
[TBL] [Abstract][Full Text] [Related]
38. The new competitive NMDA receptor antagonist CGP 40116 inhibits pilocarpine-induced limbic motor seizures and unconditioned motor behaviour in the mouse.
Starr MS; Starr BS
Pharmacol Biochem Behav; 1994 Jan; 47(1):127-31. PubMed ID: 7906888
[TBL] [Abstract][Full Text] [Related]
39. MDL 100,458 and MDL 102,288: two potent and selective glycine receptor antagonists with different functional profiles.
Kehne JH; Baron BM; Harrison BL; McCloskey TC; Palfreyman MG; Poirot M; Salituro FG; Siegel BW; Slone AL; Van Giersbergen PL
Eur J Pharmacol; 1995 Sep; 284(1-2):109-18. PubMed ID: 8549613
[TBL] [Abstract][Full Text] [Related]
40. Glycine and D: -serine, but not D: -cycloserine, attenuate prepulse inhibition deficits induced by NMDA receptor antagonist MK-801.
Kanahara N; Shimizu E; Ohgake S; Fujita Y; Kohno M; Hashimoto T; Matsuzawa D; Shirayama Y; Hashimoto K; Iyo M
Psychopharmacology (Berl); 2008 Jun; 198(3):363-74. PubMed ID: 18437299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
